• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

O-连接的N-乙酰葡糖胺化将致癌信号与癌症表观遗传学联系起来。

O-GlcNAcylation links oncogenic signals and cancer epigenetics.

作者信息

Sun Lidong, Lv Suli, Song Tanjing

机构信息

Department of Biochemistry and Molecular Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan, 430030, China.

出版信息

Discov Oncol. 2021 Nov 24;12(1):54. doi: 10.1007/s12672-021-00450-5.

DOI:10.1007/s12672-021-00450-5
PMID:35201498
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8777512/
Abstract

Prevalent dysregulation of epigenetic modifications plays a pivotal role in cancer. Targeting epigenetic abnormality is a new strategy for cancer therapy. Understanding how conventional oncogenic factors cause epigenetic abnormality is of great basic and translational value. O-GlcNAcylation is a protein modification which affects physiology and pathophysiology. In mammals, O-GlcNAcylation is catalyzed by one single enzyme OGT and removed by one single enzyme OGA. O-GlcNAcylation is affected by the availability of the donor, UDP-GlcNAc, generated by the serial enzymatic reactions in the hexoamine biogenesis pathway (HBP). O-GlcNAcylation regulates a wide spectrum of substrates including many proteins involved in epigenetic modification. Like epigenetic modifications, abnormality of O-GlcNAcylation is also common in cancer. Studies have revealed substantial impact on HBP enzymes and OGT/OGA by oncogenic signals. In this review, we will first summarize how oncogenic signals regulate HBP enzymes, OGT and OGA in cancer. We will then integrate this knowledge with the up to date understanding how O-GlcNAcylation regulates epigenetic machinery. With this, we propose a signal axis from oncogenic signals through O-GlcNAcylation dysregulation to epigenetic abnormality in cancer. Further elucidation of this axis will not only advance our understanding of cancer biology but also provide new revenues towards cancer therapy.

摘要

表观遗传修饰的普遍失调在癌症中起着关键作用。靶向表观遗传异常是癌症治疗的一种新策略。了解传统致癌因素如何导致表观遗传异常具有重要的基础和转化价值。O-连接的N-乙酰葡糖胺化(O-GlcNAcylation)是一种影响生理和病理生理的蛋白质修饰。在哺乳动物中,O-GlcNAcylation由单一酶O-连接的N-乙酰葡糖胺转移酶(OGT)催化,并由单一酶O-连接的N-乙酰葡糖胺酶(OGA)去除。O-GlcNAcylation受己糖胺生物合成途径(HBP)中一系列酶促反应产生的供体UDP-GlcNAc可用性的影响。O-GlcNAcylation调节广泛的底物,包括许多参与表观遗传修饰的蛋白质。与表观遗传修饰一样,O-GlcNAcylation异常在癌症中也很常见。研究表明致癌信号对HBP酶和OGT/OGA有重大影响。在这篇综述中,我们将首先总结致癌信号如何在癌症中调节HBP酶、OGT和OGA。然后,我们将把这些知识与目前对O-GlcNAcylation如何调节表观遗传机制的理解相结合。据此,我们提出了一条从致癌信号通过O-GlcNAcylation失调到癌症表观遗传异常的信号轴。进一步阐明这条轴不仅将推进我们对癌症生物学的理解,还将为癌症治疗提供新的途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6e8/8777512/07387fa7f030/12672_2021_450_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6e8/8777512/f354472f9118/12672_2021_450_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6e8/8777512/07387fa7f030/12672_2021_450_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6e8/8777512/f354472f9118/12672_2021_450_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6e8/8777512/07387fa7f030/12672_2021_450_Fig2_HTML.jpg

相似文献

1
O-GlcNAcylation links oncogenic signals and cancer epigenetics.O-连接的N-乙酰葡糖胺化将致癌信号与癌症表观遗传学联系起来。
Discov Oncol. 2021 Nov 24;12(1):54. doi: 10.1007/s12672-021-00450-5.
2
Feedback Regulation of -GlcNAc Transferase through Translation Control to Maintain Intracellular -GlcNAc Homeostasis.通过翻译控制反馈调节 N-乙酰氨基葡萄糖转移酶以维持细胞内 N-乙酰氨基葡萄糖稳态。
Int J Mol Sci. 2021 Mar 27;22(7):3463. doi: 10.3390/ijms22073463.
3
O-GlcNAcylation in Chronic Lymphocytic Leukemia and Other Blood Cancers.O-糖基化在慢性淋巴细胞白血病和其他血液癌症中的作用。
Front Immunol. 2021 Nov 18;12:772304. doi: 10.3389/fimmu.2021.772304. eCollection 2021.
4
O-GlcNAcylation: A New Cancer Hallmark?O-糖基化:癌症的新标志?
Front Endocrinol (Lausanne). 2013 Aug 12;4:99. doi: 10.3389/fendo.2013.00099. eCollection 2013.
5
O-GlcNAcylation and O-GlcNAc Cycling Regulate Gene Transcription: Emerging Roles in Cancer.O-连接的N-乙酰葡糖胺化修饰与O-连接的N-乙酰葡糖胺循环调控基因转录:在癌症中的新作用
Cancers (Basel). 2021 Apr 1;13(7):1666. doi: 10.3390/cancers13071666.
6
Undetectable histone O-GlcNAcylation in mammalian cells.哺乳动物细胞中无法检测到的组蛋白O-连接N-乙酰葡糖胺化
Epigenetics. 2015;10(8):677-91. doi: 10.1080/15592294.2015.1060387.
7
Potential coordination role between O-GlcNAcylation and epigenetics.O-连接的N-乙酰葡糖胺糖基化(O-GlcNAcylation)与表观遗传学之间潜在的协调作用。
Protein Cell. 2017 Oct;8(10):713-723. doi: 10.1007/s13238-017-0416-4. Epub 2017 May 9.
8
O-GlcNAcylation enhances the invasion of thyroid anaplastic cancer cells partially by PI3K/Akt1 pathway.O-连接的N-乙酰葡糖胺化部分通过PI3K/Akt1信号通路增强甲状腺未分化癌细胞的侵袭能力。
Onco Targets Ther. 2015 Nov 9;8:3305-13. doi: 10.2147/OTT.S82845. eCollection 2015.
9
The Essential Role of O-GlcNAcylation in Hepatic Differentiation.O-连接的N-乙酰葡糖胺糖基化在肝脏分化中的重要作用
bioRxiv. 2023 Feb 17:2023.02.16.528884. doi: 10.1101/2023.02.16.528884.
10
[Protein O-GlcNAcylation and regulation of cell signalling: involvement in pathophysiology].[蛋白质O-连接N-乙酰葡糖胺化与细胞信号传导调控:参与病理生理学过程]
Biol Aujourdhui. 2014;208(2):109-17. doi: 10.1051/jbio/2014015. Epub 2014 Sep 8.

引用本文的文献

1
Glycomics in Human Diseases and Its Emerging Role in Biomarker Discovery.人类疾病中的糖组学及其在生物标志物发现中的新兴作用。
Biomedicines. 2025 Aug 21;13(8):2034. doi: 10.3390/biomedicines13082034.
2
O-GlcNAcylation on serine 40 of histone H2A promotes proliferation and invasion in triple-negative breast cancer.组蛋白H2A第40位丝氨酸上的O-连接N-乙酰葡糖胺化促进三阴性乳腺癌的增殖和侵袭。
Sci Rep. 2025 Mar 24;15(1):10170. doi: 10.1038/s41598-025-95394-z.
3
Loss of LRP1 Promotes Hepatocellular Carcinoma Progression via UFL1-Mediated Activation of NF-κB Signaling.

本文引用的文献

1
DOT1L O-GlcNAcylation promotes its protein stability and MLL-fusion leukemia cell proliferation.DOT1L 的 O-GlcNAcylation 促进其蛋白稳定性和 MLL 融合白血病细胞增殖。
Cell Rep. 2021 Sep 21;36(12):109739. doi: 10.1016/j.celrep.2021.109739.
2
FOXA2 inhibits doxorubicin-induced apoptosis via transcriptionally activating HBP rate-limiting enzyme GFPT1 in HCC cells.FOXA2通过转录激活肝癌细胞中HBP限速酶GFPT1来抑制阿霉素诱导的细胞凋亡。
J Physiol Biochem. 2021 Nov;77(4):625-638. doi: 10.1007/s13105-021-00829-6. Epub 2021 Jul 22.
3
O-GlcNAc modification regulates MTA1 transcriptional activity during breast cancer cell genotoxic adaptation.
LRP1缺失通过UFL1介导的NF-κB信号激活促进肝细胞癌进展。
Adv Sci (Weinh). 2024 Dec;11(45):e2401672. doi: 10.1002/advs.202401672. Epub 2024 Oct 15.
4
O-GlcNAcylation: Crosstalk between Hemostasis, Inflammation, and Cancer.O-糖基化:止血、炎症和癌症之间的串扰。
Int J Mol Sci. 2024 Sep 13;25(18):9896. doi: 10.3390/ijms25189896.
5
FOXM1 Upregulates O-GlcNAcylation Level Via The Hexosamine Biosynthesis Pathway to Promote Angiogenesis in Hepatocellular Carcinoma.FOXM1通过己糖胺生物合成途径上调O-连接的N-乙酰葡糖胺糖基化水平以促进肝细胞癌血管生成
Cell Biochem Biophys. 2024 Sep;82(3):2767-2785. doi: 10.1007/s12013-024-01393-8. Epub 2024 Jul 20.
6
Can -GIcNAc Transferase (OGT) Complex Be Used as a Target for the Treatment of Hematological Malignancies?O-连接的N-乙酰葡糖胺转移酶(OGT)复合物能否用作血液系统恶性肿瘤的治疗靶点?
Pharmaceuticals (Basel). 2024 May 22;17(6):664. doi: 10.3390/ph17060664.
7
Dissecting OGT's TPR domain to identify determinants of cellular function.解析 OGT 的 TPR 结构域,以鉴定其对细胞功能的影响因素。
Proc Natl Acad Sci U S A. 2024 May 28;121(22):e2401729121. doi: 10.1073/pnas.2401729121. Epub 2024 May 20.
8
‑GlcNAcylation mediates endometrial cancer progression by regulating the Hippo‑YAP pathway.‑GlcNAcylation 通过调控 Hippo‑YAP 通路促进子宫内膜癌进展。
Int J Oncol. 2023 Aug;63(2). doi: 10.3892/ijo.2023.5538. Epub 2023 Jun 23.
9
The Hexosamine Biosynthesis Pathway: Regulation and Function.己糖胺生物合成途径:调控与功能。
Genes (Basel). 2023 Apr 18;14(4):933. doi: 10.3390/genes14040933.
10
BAP1 in cancer: epigenetic stability and genome integrity.癌症中的BAP1:表观遗传稳定性与基因组完整性
Discov Oncol. 2022 Nov 1;13(1):117. doi: 10.1007/s12672-022-00579-x.
O-GlcNAc 修饰调节乳腺癌细胞遗传毒性适应过程中 MTA1 的转录活性。
Biochim Biophys Acta Gen Subj. 2021 Aug;1865(8):129930. doi: 10.1016/j.bbagen.2021.129930. Epub 2021 May 18.
4
The language of chromatin modification in human cancers.人类癌症中染色质修饰的语言。
Nat Rev Cancer. 2021 Jul;21(7):413-430. doi: 10.1038/s41568-021-00357-x. Epub 2021 May 17.
5
Cell death as a result of calcium signaling modulation: A cancer-centric prospective.钙信号调节导致的细胞死亡:以癌症为中心的展望。
Biochim Biophys Acta Mol Cell Res. 2021 Jul;1868(8):119061. doi: 10.1016/j.bbamcr.2021.119061. Epub 2021 May 12.
6
Protein kinase A controls the hexosamine pathway by tuning the feedback inhibition of GFAT-1.蛋白激酶 A 通过调节 GFAT-1 的反馈抑制来控制己糖胺途径。
Nat Commun. 2021 Apr 12;12(1):2176. doi: 10.1038/s41467-021-22320-y.
7
Potential role of glucosamine-phosphate N-acetyltransferase 1 in the development of lung adenocarcinoma.氨基葡萄糖-磷酸 N-乙酰转移酶 1 在肺腺癌发展中的潜在作用。
Aging (Albany NY). 2021 Mar 3;13(5):7430-7453. doi: 10.18632/aging.202604.
8
Loss of O-GlcNAcase catalytic activity leads to defects in mouse embryogenesis.O-GlcNAcase 催化活性丧失导致小鼠胚胎发生缺陷。
J Biol Chem. 2021 Jan-Jun;296:100439. doi: 10.1016/j.jbc.2021.100439. Epub 2021 Feb 19.
9
Hepatocyte nuclear factor 1 beta: A perspective in cancer.肝细胞核因子 1β:癌症研究的新视角。
Cancer Med. 2021 Mar;10(5):1791-1804. doi: 10.1002/cam4.3676. Epub 2021 Feb 13.
10
CARM1/PRMT4: Making Its Mark beyond Its Function as a Transcriptional Coactivator.CARM1/PRMT4:超越转录共激活因子功能的新标记
Trends Cell Biol. 2021 May;31(5):402-417. doi: 10.1016/j.tcb.2020.12.010. Epub 2021 Jan 20.